Cleared Traditional

CRIT-LINE HEMATOCRIT ALERT (MODIFICATION)

K953875 · In-Line Diagnostics Corp. · Gastroenterology & Urology
Jul 1996
Decision
391d
Days
Class 2
Risk

About This 510(k) Submission

K953875 is an FDA 510(k) clearance for the CRIT-LINE HEMATOCRIT ALERT (MODIFICATION), a System, Hemodialysis, Access Recirculation Monitoring (Class II — Special Controls, product code MQS), submitted by In-Line Diagnostics Corp. (Riverdale, US). The FDA issued a Cleared decision on July 23, 1996, 391 days after receiving the submission on June 28, 1995. This device falls under the Gastroenterology & Urology review panel. Regulated under 21 CFR 876.5820.

Submission Details

510(k) Number K953875 FDA.gov
FDA Decision Cleared SESE
Date Received June 28, 1995
Decision Date July 23, 1996
Days to Decision 391 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Statement

Device Classification

Product Code MQS — System, Hemodialysis, Access Recirculation Monitoring
Device Class Class II — Special Controls
CFR Regulation 21 CFR 876.5820